Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The adenovirus E1A protein both activates and represses gene expression to promote cellular proliferation and inhibit differentiation. Zusätzlich bieten wir Ihnen CREG1 Kits (16) und CREG1 Proteine (13) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 99 products:
These results indicate that CREG1 is a down-stream effector of KRAS in a sub-type of non-small cell lung cancer cells and a novel candidate biomarker or therapeutic target for KRAS mutant non-small cell lung cancer.
Results indicate that cellular repressor of E1A (zeige BCKDHA Antikörper)-stimulated gene 1 protein (CREG1) increases endothelial cell (EC) filopodia formation.
The results suggest a novel role of CREG to promote HUVEC proliferation through the ERK (zeige EPHB2 Antikörper)/cyclin E (zeige CCNE1 Antikörper) signaling pathway.
CREG can inhibit NF-kappaB (zeige NFKB1 Antikörper) activation, TNF-alpha (zeige TNF Antikörper)-induced inflammatory responses and the hyperpermeability of endothelial cells.
miR (zeige MLXIP Antikörper)-31 not only directly binds to its target gene CREG and modulates the vascular smooth muscle cells(VSMC) phenotype through this interaction, but also can be an important biomarker in diseases involving VSMC phenotypic modulation.
Suggest that CREG is a novel adventitial fibroblast phenotypic modulator in a p38MAPK (zeige MAPK14 Antikörper)-dependent manner.
CREG plays a critical role in protecting the vascular endothelium from apoptosis, and the protective effort of CREG against ECs apoptosis is through the activation of the VEGF (zeige VEGFA Antikörper)/PI3K (zeige PIK3CA Antikörper)/AKT (zeige AKT1 Antikörper) signaling pathway
Upregulation of CREG expression induced HUVEC migration.
Cooperation of CREG1 and p16 (INK4a (zeige CDKN2A Antikörper)) inhibits the expression of cyclin A (zeige CCNA2 Antikörper) and cyclin B by inhibiting promoter activity thereby decreasing mRNA and protein levels; these proteins are required for S-phase entry and G2/M transition.
Data suggest that soluble CREG protein can exert its biological function via glycosylation-independent binding to the extracellular domains 11-13 of cell surface M6P/IGF2R (zeige IGF2R Antikörper), modulating SMC (zeige DYM Antikörper) phenotypic switching from contractile to proliferative.
Study demonstrated that haplodeficiency of Creg1 exacerbated high fat diet-induced obesity, insulin (zeige INS Antikörper) resistance and dyslipidemia. In addition, Creg1+/- mice showed increased systemic and adipose tissue inflammation, possibly through activation of the NF-kappaB (zeige NFKB1 Antikörper) pathway.
CREG is a novel mediator of vascular remodeling in response to Ang II (zeige AGT Antikörper).
CREG inhibits inflammation and promotes autophagy mediated by lysosome formation; it might be a potential therapeutic target in atherosclerosis.
CREG1 deficiency influenced the maturation of lysosomes and reduced the espression of Rab7 (zeige RAB7A Antikörper), which might be involved in CREG1-induced cardiomyocyte autophagy.
Data indicate cellular repressor of E1A (zeige BCKDHA Antikörper)-stimulated gene (CREG) as a factor in regulating endothelial differentiation and vasculogenesis via VEGF (zeige VEGFA Antikörper)/PI3K/Akt (zeige AKT1 Antikörper) pathway.
CREG plays a critical role in protecting the vascular endothelium from apoptosis, and the protective effort of CREG against ECs apoptosis is through the activation of the VEGF (zeige VEGFA Antikörper)/PI3K/AKT (zeige AKT1 Antikörper) signaling pathway
These results indicate that CREG is expressed during mouse embryogenesis and might participate in the differentiation of these organs during embryogenesis.
Results show that CREG is a lysosomal protein that undergoes proteolytic maturation during biosynthesis, carries the mannose 6-phosphate recognition marker and depends on the interaction with M-6-P receptors for efficient delivery to lysosomes.
Secreted Creg inhibits cell proliferation mediated by mannose-6-phosphate/insulin-like growth factor II receptor (zeige IGF2R Antikörper) in NIH 3T3 fibroblasts.
The adenovirus E1A protein both activates and represses gene expression to promote cellular proliferation and inhibit differentiation. The protein encoded by this gene antagonizes transcriptional activation and cellular transformation by E1A. This protein shares limited sequence similarity with E1A and binds both the general transcription factor TBP and the tumor suppressor pRb in vitro. This gene may contribute to the transcriptional control of cell growth and differentiation.
cellular repressor of E1A-stimulated genes 1
, protein CREG1
, Protein CREG1
, hypothetical protein